Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.86
+0.30 (1.03%)
At close: Apr 14, 2026, 4:00 PM EDT
28.88
+0.02 (0.09%)
After-hours: Apr 14, 2026, 4:10 PM EDT
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025.
Employees
558
Change
n/a
Growth
n/a
Revenue / Employee
$2,340,350
Profits / Employee
$675,192
Market Cap
1.92B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptive Biotechnologies | 624 |
| Agios Pharmaceuticals | 540 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Innoviva | 159 |
| AnaptysBio | 104 |
GLPG News
- 14 days ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 14 days ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 19 days ago - Galapagos Announces Nomination of Gino Santini to its Board of Directors - GlobeNewsWire
- 19 days ago - Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - GlobeNewsWire
- 22 days ago - Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 4 weeks ago - Galapagos Receives Transparency Notification from Bank of America - GlobeNewsWire
- 5 weeks ago - Galapagos Receives Transparency Notifications from Bank of America - GlobeNewsWire
- 5 weeks ago - Galapagos Creates New Subscription Right Plan - GlobeNewsWire